GFACX | SUTZX | GFACX / SUTZX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 3 years | - |
Gain YTD | 2.980 | -0.823 | -362% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 304B | 67.1M | 453,055% |
Annual Yield % from dividends | 0.00 | 0.46 | - |
Returns for 1 year | 10.15 | -14.84 | -68% |
Returns for 3 years | 17.69 | -14.76 | -120% |
Returns for 5 years | 32.83 | N/A | - |
Returns for 10 years | 55.63 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYBOX | 58.38 | -0.21 | -0.36% |
Rydex Biotechnology A | |||
EPLIX | 21.88 | -0.18 | -0.82% |
NYLI Epoch U.S. Equity Yield Inv Class | |||
RMFCX | 57.23 | -0.62 | -1.07% |
American Funds American Mutual R3 | |||
GCTRX | 47.78 | -1.04 | -2.13% |
Goldman Sachs US Tax-Managed Eq R6 | |||
VLLIX | 38.78 | -1.25 | -3.12% |
Value Line Larger Companies Focus Instl |